You have 9 free searches left this month | for more free features.

Myotonia

Showing 1 - 25 of 51

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Dystrophic Myotonia Trial in Nice (Questionnaire for Non-dystrophic myotonias)

Not yet recruiting
  • Non-Dystrophic Myotonia
  • Questionnaire for Non-dystrophic myotonias
  • Nice, Alpes Maritimes, France
    Nice University Hospital
Nov 13, 2023

Myotonic Dystrophy 1 Trial in Palo Alto

Active, not recruiting
  • Myotonic Dystrophy 1
    • Palo Alto, California
      Stanford Universtiy
    Oct 12, 2023

    Non-Dystrophic Myotonia Trial in Copenhagen (Lamotrigine, Namuscla)

    Recruiting
    • Non-Dystrophic Myotonia
    • Copenhagen, Denmark
      Copenhagen Neuromuscular Center, department of Neurology, Rigsho
    Dec 5, 2022

    Myotonic Dystrophy, Congenital Myotonic Dystrophy, Myotonic Dystrophy 1 Trial in Oakland (Patient-entered data)

    Recruiting
    • Myotonic Dystrophy
    • +15 more
    • Patient-entered data
    • Oakland, California
      Myotonic Dystrophy Foundation
    Oct 31, 2022

    Using MRI in Non-dystrophic Myotonia to Access Muscle

    Recruiting
    • Paramyotonia Congenita
    • Nondystrophic Myotonia
    • MRI
    • Copenhagen, Denmark
      Neuromuscular Center Rigshospitalet
    Sep 14, 2021

    Hypertrofic Muscles in Patients With Non-Dystrophic Myotonia

    Recruiting
    • Non-Dystrophic Myotonia
    • Myotonia Congenita
      • Copenhagen, Denmark
        Rigshospitalet
      Mar 16, 2021

      Non-Dystrophic Myotonia Trial in London (Mexiletine, Lamotrigine 25Mg Oral Tablet, Extended Release)

      Recruiting
      • Non-Dystrophic Myotonia
      • Mexiletine
      • Lamotrigine 25Mg Oral Tablet, Extended Release
      • London, United Kingdom
        University College London Hospital
      Aug 23, 2021

      Adult Patients With Non-dystrophic Myotonic Disorders

      Recruiting
      • Myotonic Dystrophy
      • Paris, Cedex, France
      • +5 more
      Feb 24, 2021

      Myotonic Dystrophy 1 Trial in Jette (Low frequency repetitive stimulation)

      Completed
      • Myotonic Dystrophy 1
      • Low frequency repetitive stimulation
      • Jette, Brussels Hoofdstedelijk Gewest, Belgium
        UZ Brussel
      Dec 21, 2022

      Myotonic Dystrophy Type 1 (DM1) Trial in Vikersund (Tyromotion Amadeo and Armeo Senso)

      Recruiting
      • Myotonic Dystrophy Type 1 (DM1)
      • Tyromotion Amadeo and Armeo Senso
      • Vikersund, Viken, Norway
        Vikersund Rehabilitation Center
      Sep 26, 2022

      Clinical Outcome Measures in Myotonic Dystrophy Type 2

      Completed
      • Myotonic Dystrophy Type 2
      • DM1-ActivC
      • +18 more
      • Munich, Bavaria, Germany
        Friedrich-Baur-Institute, Dep. of Neurology Klinikum der Univers
      Feb 19, 2020

      Myotonia Congenita, Paramyotonia Congenita, Myotonic Dystrophy 1 Trial in Columbus (Ranolazine)

      Completed
      • Myotonia Congenita
      • +2 more
      • Columbus, Ohio
        The Ohio State University Wexner Medical Center
      Mar 1, 2019

      Intensive Care Unit and in Primary Myopathies

      Completed
      • Sepsis
      • Primary Myopathies
        • Basel, Switzerland
          University of Basel Hospital
        Nov 25, 2021

        Myotonic Disorders Trial in Paris (Mexiletine)

        Recruiting
        • Myotonic Disorders
        • Paris, France
          Hôpital Necker-Enfants-Malades
        Dec 1, 2021

        Myotonic Dystrophy Trial in Paris (Mexiletine)

        Recruiting
        • Myotonic Dystrophy
        • Paris, France
          Hôpital Necker-Enfants-Malades
        Sep 9, 2021

        PhenoDM1 (Myotonic Dystrophy Type 1 Natural History Study)

        Completed
        • Myotonic Dystrophy Type 1
          • Newcastle Upon Tyne, Tyne And Wear, United Kingdom
          • +1 more
          Apr 12, 2021

          Congenital Myotonic Dystrophy Trial in Worldwide (Tideglusib, Placebo)

          Recruiting
          • Congenital Myotonic Dystrophy
          • Little Rock, Arkansas
          • +14 more
          Aug 11, 2022

          Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)

          Terminated
          • Myotonic Dystrophy Type-1
          • Myotonic Dystrophy Type-2
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Nov 2, 2021

            Congenital Myotonic Dystrophy Trial in Worldwide (Tideglusib)

            Enrolling by invitation
            • Congenital Myotonic Dystrophy
            • Little Rock, Arkansas
            • +10 more
            Nov 15, 2021

            Stellate Ganglion, Parkinson Disease Trial in Guangzhou (Treatment (Stellate ganglion block;Oral standard anti-Parkinson's

            Recruiting
            • Stellate Ganglion
            • Parkinson Disease
            • Treatment (Stellate ganglion block;Oral standard anti-Parkinson's drugs)
            • Treatment (Oral standard anti-Parkinson's drugs)
            • Guangzhou, Guangdong, China
              Zhujiang Hospiatal
            Oct 26, 2023

            Myotonic Dystrophy Type 1 and Type 2 Trial (Mexiletine 167 mg, Placebo)

            Not yet recruiting
            • Myotonic Dystrophy Type 1 and Type 2
            • Mexiletine 167 mg
            • Placebo
            • (no location specified)
            Jan 21, 2021

            DM1 Patients in China

            Enrolling by invitation
            • Myotonic Dystrophy 1
            • Brain MRI scan
            • Shanghai, China
              Huashan Hospital
            Oct 20, 2023

            's Study of a Smartphone Application for Periodic Paralysis

            Recruiting
            • Periodic Paralyses
              • Paris, Île-de-France, France
                RaDiCo-PP
              Jul 26, 2023

              Brain Structure and Clinical Endpoints in Myotonic Dystrophy

              Recruiting
              • Myotonic Dystrophy Type 2
              • Non-interventional study
              • Winston-Salem, North Carolina
                Wake Forest University Health Sciences
              May 2, 2023

              Myotonic Dystrophy 1 Trial in Oslo (Moderate-Heavy Resistance Exercise)

              Recruiting
              • Myotonic Dystrophy 1
              • Moderate-Heavy Resistance Exercise
              • Oslo, Norway
                Norwegian School of Sport Sciences
              Aug 30, 2021